Search Results 2831-2840 of 40269 for Two-phase

  1. An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. Cataract surgery - Mayo Clinic

    Eyeglasses or contact lenses are needed to correct vision after surgery. During the procedure. Two of the steps in cataract surgery Cataract surgery Enlarge ...

  3. Bacteriophage Therapy in Patients With Prosthetic Joint Infections Who Previously Failed Surgery for PJI (ACTIVE2) - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  4. Postherpetic neuralgia - Symptoms and causes - Mayo Clinic

    Shingrix is given in two doses, 2 to 6 months apart. With two doses, Shingrix is more than 90% effective in preventing shingles and postherpetic ...

  5. A Study to Evaluate Topical VT30 to Treat Patients with Venous/Lymphatic Malformations Associated with PIK3CA or TEK Gene Mutations - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  6. Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  7. Study to Evaluate CCS1477 in Haematological Malignancies - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  8. Small Lymphocytic Lymphoma Clinical Trials - Mayo Clinic Research

    ... phase 2 dose (RP2D) of APG-2575. Pirtobrutinib And Venetoclax With MRD Detection For Previously Untreated Chronic Lymphocytic Leukemia Rochester, MN. This phase ...

  9. A Phase 1 Study Of Anitocabtagene Autoleucel For The Treatment Of Subjects With Non-oncology Plasma Cell-related Diseases - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. A Study Of Crenezumab In Participants With Mild To Moderate Alzheimer Disease - Mayo Clinic

    Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...